Contemporary insights into cancer. Risks, perspectives, expectations Lunch Mechanisms of tumor growth and differentiation

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Contemporary insights into cancer. Risks, perspectives, expectations. 13.00-14.00 Lunch 14.00-15.30 Mechanisms of tumor growth and differentiation"

Transcription

1 Contemporary insights into cancer. Risks, perspectives, expectations Saturday, Feb 16 th Lunch Mechanisms of tumor growth and differentiation Prof. Alicja Józkowicz Role of micrornas in tumor growth and differentiation Agata Szade Role of heme oxygenase-1 in squamous cell carcinoma Maciej Ciesla Novel therapies of rhabdomyosarcoma Jacek Stępniewski Teratoma formation as the model for pluripotency of stem cells Coffee break and poster viewing Angiogenesis and anti-angiogenic therapies Dr Agnieszka Łoboda Hypoxia-driven tumor vascularisation Dr Agnieszka Jaźwa Regulatable vectors for pro-and anti-angiogenic therapies Prof. Józef Dulak micrornas in tumor angiogensis: tools and targets Anna Grochot-Przeczek Proangiogenic progenitor cells Krzysztof Szade In vivo imaging of angiogenesis and tumor growth: novel models Witold Nowak New approaches to treatment of leukemias Urszula Florczyk Role of Nrf2 in tumor angiogenesis Magdalena Kozakowska Acellular proangiogenic therapies Welcome party and reminiscences

2 Sunday, Feb 17 th Targeted therapies Inaugural lecture: Prof. Tomasz Grodzicki Dark side of the moon - consequences of curing cancer Prof. Hanna Rokita Anti-GD2 ganglioside strategy in treatment of neuroblastoma Dr Irena Horwacik Application of molecular mimicry to target GD2 ganglioside Durbas Małgorzata A role of aurora A kinase and its substrates in 14G2a monoclonal antibody toxicity against human neuroblastoma Prof. Grzegorz Bartosz Multidrug transporters and their role in the failure of cancer chemotherapy Anti-cancer molecular biology strategies Dr Dominika Nowis Influence of statins on glucose uptake by human cells Prof. Claudine Kieda Angiogenesis normalization strategies: molecular mechanism in tumor therapy Prof. Joanna Bereta Genetically-modified Salmonella - a new option in cancer therapy? Maria Czarnek Role of ADAM17 in a murine model of colon carcinoma Dr Monika Bzowska Poster session I Tumor-targeting with monoclonal antibodies

3 Monday, Feb 18 th First premedical aid training (in Polish) Marcin Zawrotniak Poster session II Radiotherapy of cancer Prof. Howard Halpern Application of EPR O 2 Imaging to Radiation Biology and Therapy Prof. Bożena Romanowska-Dixon A new treatment modality of intraocular neoplasm - proton radiotherapy in Kraków Prof. Paweł Olko New opportunities for tumor therapy using proton beam Dr Martyna Elas DNA damage, protein expression and migration of melanoma cells irradiated with proton beam Phototherapy of cancer Dr Janusz Dąbrowski "Luz11 - a novel photosensitizer for photodynamic therapy on its way from synthesis to clinical trials Martyna Krzykawska F 2 Bmet-PDT effects on vasculature Dr Jolanta Saczko Photodynamic therapy and its modification in cancer cells Monika Jakubowska Double-faced roles of nitric oxide in photodynamic therapy of cancer: our friend or enemy Anita Burkat-Dulak, Justyna Morawska-Płoskonka Delivering innovation in life science branch Student s Science Club

4 Tuesday, Feb 19 th Immunotherapy of cancer Prof. Chantal Pichon RNA-based vaccines Prof. Richard Daniellou "Immunostimulating glycans in cancer Dr Mateusz Kwitniewski DNA methylation and cancer immunotherapy Aleksandra Pęcak Aptamer based approach to target p53-mdm2 interaction in cancer Novel ideas of anti-cancer therapy Prof. Andrzej Mackiewicz Immunotargeting human melanoma stem cells with Hyper-IL-6 gene modified whole cell vaccine Łukasz Kalinowski, Dr Jerzy Pieczykolan From scientific concept to preclinical evaluation - 3CLA - targeted anticancer therapy Justyna Supel Malopolska Centre of Biotechnology Dr Tomasz Rzymski Conference dinner Perspectives on Development of Novel Classes of Cyclin Dependent Kinase Inhibitors as Anticancer Drugs

5 Wednesday, Feb 20 th Skiing competition Novel ideas of anti-cancer therapy Maja Swoboda, Dr Arkadiusz Miciałkiewicz NEXT GENeration SCIENCE - from the sequence to the change. The story how Life Technologies is improving genome research providing tools for genetic engineering. The easy way to advanced regenerative medicine Prof. Alicja Ratuszna A new perspective for the education and science in the modern labs in Silesian Center of Education and Interdisciplinary Research Michał Sarna Nanomechanical analysis of melanoma cells 16: Coffee break and poster viewing Carcinogenesis and tumor development Prof. Tadeusz Sarna Are Transition Metal the Missing Risk Factors for Cutaneous Malignant Melanoma? Prof. Ewa Sikora Therapy induced senescence - hope or hype? Dr Maja Grabacka Targeting tumor cell metabolism as an alternative therapeutic perspective" Dr Agnieszka Wolnicka-Głubisz UV-induced melanoma in HGF/SF transgenic mouse Debate: Introducing new therapies into clinic

Abstracts of the. BIO 2014 Congress. 1st Congress of the Polish Biochemistry, Cell Biology, Biophysics and Bioinformatics

Abstracts of the. BIO 2014 Congress. 1st Congress of the Polish Biochemistry, Cell Biology, Biophysics and Bioinformatics 1st Congress of the Polish Biochemistry, Cell Biology, Biophysics and Bioinformatics 49th Meeting of the Polish Biochemical Society 12th Conference of the Polish Society for Cell Biology 16th Meeting of

More information

CURRICULUM OVERVIEW - 3-YEAR PHYSIOTHERAPY PROGRAM. Pass/fail /Examination Prof. Małgorzata Bruska, MD, PhD. Hours (total)

CURRICULUM OVERVIEW - 3-YEAR PHYSIOTHERAPY PROGRAM. Pass/fail /Examination Prof. Małgorzata Bruska, MD, PhD. Hours (total) CURRICULUM OVERVIEW - 3-YEAR PROGRAM FIRST YEAR Course Course coordinator Name of Chair/Department GROSS ANATOMY PHYSIOLOGY MEDICAL BIOLOGY BIOCHEMISTRY BIOPHYSICS PHILOSOPHY SOCIOLOGY ETHICS AND DEONTOLOGY

More information

Future Oncology: Technology, Products, Market and Service Opportunities

Future Oncology: Technology, Products, Market and Service Opportunities Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter

More information

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1 1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY

More information

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods

More information

Report on twinning short visit within the WP1 Task 1.11 of BASTION project

Report on twinning short visit within the WP1 Task 1.11 of BASTION project Report on twinning short visit within the WP1 Task 1.11 of BASTION project Science Business, 16-18 Feb 2015, Brussels Karolina Dzwonek Jakub Golab Jakub Golab, BASTION project coordinator and Karolina

More information

Session I From biochemistry to biotechnology, part I BEL-AMI Hotel Conference Room Chair: Joanna Bereta

Session I From biochemistry to biotechnology, part I BEL-AMI Hotel Conference Room Chair: Joanna Bereta PROGRAMME TUESDAY, 16 FEBRUARY 2016 10:30 Departure from Kraków Faculty of Biochemistry, Biophysics and Biotechnology, 7 Gronostajowa St., 30-387 Krakow 12:00-13:00 Registration 14:05-14:15 Opening of

More information

1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT

1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT 1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT Learning that your pet has a diagnosis of cancer can be overwhelming. We realize that your pet

More information

THE CENTRE FOR PHARMACEUTICAL ONCOLOGY

THE CENTRE FOR PHARMACEUTICAL ONCOLOGY THE CENTRE FOR PHARMACEUTICAL ONCOLOGY Application for Membership Send Completed Form to: sam.dalfonso@utoronto.ca Name (Last, First): Current Position: o Professor o Associate Professor o Assistant Professor

More information

CURRICULUM OVERVIEW - 5-YEAR DDS PROGRAM. /Examination (total) GROSS ANATOMY Prof. Małgorzata Bruska, Chair and Department of

CURRICULUM OVERVIEW - 5-YEAR DDS PROGRAM. /Examination (total) GROSS ANATOMY Prof. Małgorzata Bruska, Chair and Department of CURRICULUM OVERVIEW - 5-YEAR DDS PROGRAM FIRST YEAR Course Course coordinator Chair/Department GROSS ANATOMY Prof. Małgorzata Bruska, 150 50 100 0 11 Examination MD, Anatomy BIOPHYSICS Marek Tuliszka,

More information

Javier Fombona / FACULTAD DE Formación del Profesorado y Educación (Univ. Oviedo) Información OFERTA ESTUDIOS EN POLONIA LUBLIN

Javier Fombona / FACULTAD DE Formación del Profesorado y Educación (Univ. Oviedo) Información OFERTA ESTUDIOS EN POLONIA LUBLIN Información OFERTA ESTUDIOS EN POLONIA LUBLIN Course Subject area Form of the class Name of the academic teacher Semester Type of An introduction to human biopsychological development across the life span

More information

The Agenda of 2nd International Scientific Conference. Epimilitaris 2013 Bioterrorism

The Agenda of 2nd International Scientific Conference. Epimilitaris 2013 Bioterrorism The Agenda of 2nd International Scientific Conference Epimilitaris 2013 Bioterrorism 09.09.2013 Day 1 13.00-14.30 Registration of the conference participants Opening session Host: Ryan Madden, Zbigniew

More information

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer

More information

Conference opening 11.15 13.15. Strona 1 z 5

Conference opening 11.15 13.15. Strona 1 z 5 THE SCIENTIFIC CONFERENCE TO CELEBRATE THE INTERNATIONAL YEAR OF STATISTICS ŁÓDŹ 17-18 October 2013 STATISTICS KNOWLEDGE DEVELOPMENT 17 October 2013 9.00 9.15 Conference opening Statistics in the face

More information

SCHEDULE - FALL 2013/14

SCHEDULE - FALL 2013/14 Economics, International Relations and Social Sciences (); Finance, Accounting and Banking (F,A&B); Informatics (Computer Science), Quantitative Methods and Technology (I,MM&T); Management Sciencs ();

More information

International Scientific Conference

International Scientific Conference International Scientific Conference Under the Patronage of Minister of Sport and Turism Andrzej Biernat Silesian Voivode Piotr Litwa Major of Katowice Piotr Uszok His Magnificence, Rector of Jerzy Kukuczka

More information

The ASGCT invites you to submit your research to the largest scientific conference of its kind!

The ASGCT invites you to submit your research to the largest scientific conference of its kind! American Society of Gene & Cell Therapy A N N U A L M E E T I N G th May 16-19 2 0 1 2 Philadelphia PA USA The ASGCT invites you to submit your research to the largest scientific conference of its kind!

More information

Biochemistry Major Talk 2014-15. Welcome!!!!!!!!!!!!!!

Biochemistry Major Talk 2014-15. Welcome!!!!!!!!!!!!!! Biochemistry Major Talk 2014-15 August 14, 2015 Department of Biochemistry The University of Hong Kong Welcome!!!!!!!!!!!!!! Introduction to Biochemistry A four-minute video: http://www.youtube.com/watch?v=tpbamzq_pue&l

More information

Abstracts of the VIII Parnas Conference. Warsaw, Poland August 27 31, 2011

Abstracts of the VIII Parnas Conference. Warsaw, Poland August 27 31, 2011 Abstracts of the VIII Parnas Conference Warsaw, Poland August 27 31, 2011 Patronage: Minister of Foreign Affairs Mr. Radoslaw Sikorski Minister of Science and Higher Education Prof. Barbara Kudrycka Honorary

More information

Tuesday 22.09.2015 CONFERENCE PROGRAMME/1

Tuesday 22.09.2015 CONFERENCE PROGRAMME/1 CONFERENCE PROGRAMME/1 11:00 13:00 Workshop - room 3 building Z1 (entrance by the building Z) 13:00 14:45 Registration - CKU 13:30 14:30 Lunch - CKU 14:45 15:00 Opening of the Conference - CKU Plenary

More information

Stem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine

Stem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine Stem Cells and Inner Ear Cell Regeneration Stefan Heller Stanford University School of Medicine Embryonic stem cells Induced pluripotent stem cells Somatic stem cells 50 µm Derived from the inner cell

More information

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi Cancer SBL101 James Gomes School of Biological Sciences Indian Institute of Technology Delhi All Figures in this Lecture are taken from 1. Molecular biology of the cell / Bruce Alberts et al., 5th ed.

More information

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions

More information

MOTION FOR THE RESOLUTION BY THE COMMITTEE ON USING EMBRYONIC STEM CELLS

MOTION FOR THE RESOLUTION BY THE COMMITTEE ON USING EMBRYONIC STEM CELLS Wrocław, September 2010 MOTION FOR THE RESOLUTION BY THE COMMITTEE ON USING EMBRYONIC STEM CELLS The use of embryonic stem cells: Blessing or Curse? What are the opportunities and threats of this technology?

More information

Fee-for-service cores for Investigational New Drug enabling studies

Fee-for-service cores for Investigational New Drug enabling studies UC DAVIS INSTITUTE FOR REGENERATIVE CURES Fee-for-service cores for Investigational New Drug enabling studies Pipeline pathway at UC Davis Institute for Regenerative Cures Basic Research Proof of Concept

More information

2nd BALTIC STEM CELL MEETING

2nd BALTIC STEM CELL MEETING 2nd BALTIC STEM CELL MEETING 31st May 2nd June 2013 Szczecin, Poland GENERAL INFORMATION Organized by: POMERANIAN MEDICAL UNIVERSITY IN SZCZECIN In collaboration with: JAGIELLONIAN UNIVERSITY IN KRAKOW

More information

CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010

CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010 CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010 Organisers S. Gail Eckhardt, University of Colorado Denver, Aurora, USA Roy S. Herbst, The University of Texas MD Anderson

More information

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.

More information

Patronage requested A. ANICHINI (MILAN) M.P. COLOMBO (MILAN) V. BRONTE (VERONA) M. DEL VECCHIO (MILAN) M. DI NICOLA (MILAN) M.

Patronage requested A. ANICHINI (MILAN) M.P. COLOMBO (MILAN) V. BRONTE (VERONA) M. DEL VECCHIO (MILAN) M. DI NICOLA (MILAN) M. Patronage requested Faculty A. ANICHINI (MILAN) M.P. COLOMBO (MILAN) V. BRONTE (VERONA) M. DEL VECCHIO (MILAN) M. DI NICOLA (MILAN) M. FIGINI (MILAN) J. GALON (PARIS) G. KROEMER (PARIS) M. MAIO (SIENA)

More information

Scientific Programme

Scientific Programme Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico

More information

MRC perspectives? Colin Blakemore

MRC perspectives? Colin Blakemore MRC perspectives? Colin Blakemore The past (BC): some achievements in basic research Chemical transmission in the neuromuscular junction and in synapses Nerve impulse propagation and muscle contraction

More information

Update on Clinical Trials and Foundation Funded Grants

Update on Clinical Trials and Foundation Funded Grants Update on Clinical Trials and Foundation Funded Grants Mary Hesdorffer, MS, APRN-BC Medical Liaison Meso Foundation www.curemeso.org Delivering the Diagnosis Delivering the Diagnosis Day 1 Taking control

More information

Conference: Photography among the Humanities National Library, December 12-13 2013

Conference: Photography among the Humanities National Library, December 12-13 2013 Conference: Photography among the Humanities National Library, December 12-13 2013 Program Thursday, December 12 2013 National Library in Warsaw 8.00 8.30 Registration 8.30 8.40 Welcome: Dr Tomasz Makowski

More information

63 Grzybowska St., Warsaw, Poland CONFERENCE PROGRAMME. Plenary session 1: The Education of Future Generations

63 Grzybowska St., Warsaw, Poland CONFERENCE PROGRAMME. Plenary session 1: The Education of Future Generations Educational Conference The Qualifications System A Development Tool for Poland and Europe Wednesday, 6 November 2013, Hilton Hotel, Warsaw Hall II+III 63 Grzybowska St., Warsaw, Poland CONFERENCE PROGRAMME

More information

Biological Therapies for Cancer

Biological Therapies for Cancer Biological Therapies for Cancer Key Points Biological therapies use the body's immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Biological therapies

More information

Fundraising and Research Objectives

Fundraising and Research Objectives THE EHE FOUNDATION THE EHE RARE CANCER CHARITY (UK)* THE EHE RARE CANCER FOUNDATION (AUSTRALIA)* Fundraising and Research Objectives Thank you for taking the time to find and engage with our Fundraising

More information

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of

More information

R508 A NEW NON-TOXIC DRUG TREATMENT THAT KILLS CANCER

R508 A NEW NON-TOXIC DRUG TREATMENT THAT KILLS CANCER WE NEED YOUR HELP TESTING R508 A NEW NON-TOXIC DRUG TREATMENT THAT KILLS CANCER WE NEED $25,000 FOR CURRENT TESTING OF THIS POWERFUL NEW CANCER TREATMENT TABLE OF CONTENTS WHAT YOU NEED TO KNOW ABOUT R508

More information

Course Coordinators. 4-Year MD Program. 1 st year

Course Coordinators. 4-Year MD Program. 1 st year 4-Year MD Program Course Coordinators 1 st year Behavioral Sciences Department of Old Age Psychiatry & Psychotic Disorders Head of Department: Prof. Iwona Kłoszewska MD, PhD Coordinator: Marcin Flirski

More information

New strategies in anticancer therapy

New strategies in anticancer therapy 癌 症 診 療 指 引 簡 介 及 臨 床 應 用 New strategies in anticancer therapy 中 山 醫 學 大 學 附 設 醫 院 腫 瘤 內 科 蔡 明 宏 醫 師 2014/3/29 Anti-Cancer Therapy Surgical Treatment Radiotherapy Chemotherapy Target Therapy Supportive

More information

Jobs in my family. Technikum Ekonomiczne. Class I TE

Jobs in my family. Technikum Ekonomiczne. Class I TE Jobs in my family Technikum Ekonomiczne Class I TE Aleksandra Drygas My parents They run their own clothing store. My brother Wojtek works in the UK and the Canary Islands as a driver and work inspector.

More information

Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference

Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Two New Clinical Programs and Significant Expansion of Cancer Pipeline Planned for 2004 SOUTH SAN FRANCISCO, Calif., Jan. 13 /PRNewswire-FirstCall/

More information

AGH - ZEISS Workshop on Focused Ion Beam techniques. Kraków, 9-10.06.2009

AGH - ZEISS Workshop on Focused Ion Beam techniques. Kraków, 9-10.06.2009 AGH - ZEISS Workshop on Focused Ion Beam techniques Kraków, 9-10.06.2009 AGH University of Science and Technology Faculty of Metal Engineering and Industrial Computer Science Al. Mickiewicza 30, 30-059

More information

Outline. Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment. Introduction. Current clinical practice

Outline. Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment. Introduction. Current clinical practice Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment Radiation Biology Outline Introduction: Predictive assays in radiation therapy Examples for specific tumors Immunotherapy Summary

More information

First Announcement. Dear Colleagues, dear Friends,

First Announcement. Dear Colleagues, dear Friends, First Announcement Dear Colleagues, dear Friends, On behalf of the Rector of the Jagiellonian University prof. Wojciech Nowak, the President of the Committee of Therapy and Drug Research of the Polish

More information

Groundbreaking Collaborative Clinical Trial Launched

Groundbreaking Collaborative Clinical Trial Launched Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)

More information

1-2 SEPTEMBER 2016 INTERNATIONAL CULTURAL CENTRE RYNEK GŁÓWNY 25, KRAKÓW

1-2 SEPTEMBER 2016 INTERNATIONAL CULTURAL CENTRE RYNEK GŁÓWNY 25, KRAKÓW 1-2 SEPTEMBER 2016 INTERNATIONAL CULTURAL CENTRE RYNEK GŁÓWNY 25, KRAKÓW XII INTERNATIONAL SYMPOSIUM INDUSTRIAL PROPERTY IN THE INNOVATIVE ECONOMY STARTUPS IN THE WORLD OF INNOVATION Under honorary patronage

More information

Preliminary Program. Thursday, October 18 th, Friday, October 19 th, :00-15:00 HPV AND ONCOGENIC VIRUSES

Preliminary Program. Thursday, October 18 th, Friday, October 19 th, :00-15:00 HPV AND ONCOGENIC VIRUSES Thursday, October 18 th, 2012 13:00-15:00 HPV AND ONCOGENIC VIRUSES A McBride, T Meyer 13:00 13:10 Welcome (Stockfleth, Trefzer, Nindl) 13:10 13:30 The Role of Mast Cells in the Defence against Viruses

More information

2 nd International Scientific and Training Conference International Day of Physiotherapy

2 nd International Scientific and Training Conference International Day of Physiotherapy 40th Anniversary of Faculty of Health Sciences Poznan University of Medical Sciences 2 nd International Scientific and Training Conference International Day of Physiotherapy June 26-27, 2015r. Dear Colleagues

More information

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.

More information

63 Grzybowska St., Warsaw, Poland DRAFT PROGRAMME. Michał Federowicz PhD, Director, Educational Research Institute

63 Grzybowska St., Warsaw, Poland DRAFT PROGRAMME. Michał Federowicz PhD, Director, Educational Research Institute Educational Conference The Qualifications System A Development Tool for Poland and Europe Wednesday, 6 November 2013, Hilton Hotel, Warsaw Hall II+III 63 Grzybowska St., Warsaw, Poland DRAFT PROGRAMME

More information

2nd BALTIC STEM CELL MEETING

2nd BALTIC STEM CELL MEETING 2nd BALTIC STEM CELL MEETING 31st May 2nd June 2013 Szczecin, Poland GENERAL INFORMATION Organized by: POMERANIAN MEDICAL UNIVERSITY IN SZCZECIN In collaboration with: JAGIELLONIAN UNIVERSITY IN KRAKOW

More information

58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA. First Announcement

58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA. First Announcement SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA ABSTRACT DEADLINE May 2, 2016 First Announcement Scientific Coordinators Davide Melisi (Verona) Giampaolo Tortora (Verona) Local Scientific Committee Vincenzo

More information

Support structure for genetic material

Support structure for genetic material Support structure for genetic material 1 Making proteins in the RER Making copies of humans 2 Making copies of cells Making copies of genetic material 3 Making copies of genetic material Making copies

More information

Research in Biotechnology

Research in Biotechnology INSTITUTE OF BIOMEDICINE AND BIOTECHNOLOGY OF CANTABRIA INSTITUTO DE BIOMEDICINA Y BIOTECNOLOGIA DE CANTABRIA UC Summer Programs 2015 Research in Biotechnology http://www.unican.es/en/summerprograms/ Venue

More information

Lineage-Specific Differentiation of Pluripotent Human Embryonic Stem Cells and its Implications for the Future of Cell Therapy

Lineage-Specific Differentiation of Pluripotent Human Embryonic Stem Cells and its Implications for the Future of Cell Therapy San Diego Regenerative Medicine Institute Human Stem Cells Key to Regeneration Lineage-Specific Differentiation of Pluripotent Human Embryonic Stem Cells and its Implications for the Future of Cell Therapy

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON FOLLOW-UP OF PATIENTS ADMINISTERED WITH GENE THERAPY MEDICINAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON FOLLOW-UP OF PATIENTS ADMINISTERED WITH GENE THERAPY MEDICINAL PRODUCTS European Medicines Agency London, 30 May 2008 Doc. Ref. EMEA/CHMP/GTWP/60436/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON FOLLOW-UP OF PATIENTS ADMINISTERED WITH GENE THERAPY

More information

Cytotoxic and Biotherapies Credentialing Programme Module 2

Cytotoxic and Biotherapies Credentialing Programme Module 2 Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal

More information

Achievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for

Achievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for Achievements Report August 2015 CURING CANCER Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for cancer? Since cancer is complex and comes in many forms, its

More information

The Role of Gene Therapy in Cancer Treatment. Rehan Mujahid. Abstract

The Role of Gene Therapy in Cancer Treatment. Rehan Mujahid. Abstract The Role of Gene Therapy in Cancer Treatment Rehan Mujahid Abstract Cancer is one of the major diseases in the world. This paper explores the biology of cancer cells and explains how they are originated.

More information

9 th USTKA ONCOLOGY DAYS * USTKA, SEPTEMBER 6 9, 2012 * AGENDA

9 th USTKA ONCOLOGY DAYS * USTKA, SEPTEMBER 6 9, 2012 * AGENDA September 6, 2012 (Thursday) 9 th USTKA ONCOLOGY DAYS * USTKA, SEPTEMBER 6 9, 2012 * AGENDA 2 pm 6 pm SESSION FOR NURSES Nutrition of oncological patients Under the patronage of the Polish Society of Oncology

More information

Colorectal Cancer Treatment

Colorectal Cancer Treatment Scan for mobile link. Colorectal Cancer Treatment Colorectal cancer overview Colorectal cancer, also called large bowel cancer, is the term used to describe malignant tumors found in the colon and rectum.

More information

immunotherapy a guide for the patient

immunotherapy a guide for the patient immunotherapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2 immunotherapy... 5 Monoclonal Antibodies... 6 Vaccines... 7 Adoptive T-Cell Transfer... 8 Oncolytic Viruses...

More information

BLU-554, A Novel, Potent and Selective Inhibitor of FGFR4 for the Treatment of Liver Cancer

BLU-554, A Novel, Potent and Selective Inhibitor of FGFR4 for the Treatment of Liver Cancer BLU-554, A Novel, Potent and Selective Inhibitor of FGFR4 for the Treatment of Liver Cancer Dr Klaus Hoeflich, PhD Director of Biology, Blueprint Medicines Disclosures Employee and shareholder of Blueprint

More information

International Scientific Conference Identity and stereotypes Jews and Poles October 4, 2012 r. Jan Długosz Univeristy in Czestochowa

International Scientific Conference Identity and stereotypes Jews and Poles October 4, 2012 r. Jan Długosz Univeristy in Czestochowa INVITATION International Scientific Conference Identity and stereotypes Jews and Poles October 4, 2012 r. Jan Długosz Univeristy in Czestochowa Organizer: Institute of Political Sciences Jan Dlugosz The

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

FACULTY OF MEDICAL SCIENCE

FACULTY OF MEDICAL SCIENCE Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern

More information

Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?

Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype? Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in

More information

1st January 2014 Wednesday

1st January 2014 Wednesday 1st January 2014 Wednesday January 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 February _ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

More information

The ethics of stem cell research and treatment

The ethics of stem cell research and treatment The ethics of stem cell research and treatment Bernard Lo, M.D. March 12, 2009 1 hesc: ethical controversies Moral status of embryo? Clearly a potential person Some believe a person with rights Is hesc

More information

Synthetic Biology, A New Paradigm For Biological Discovery

Synthetic Biology, A New Paradigm For Biological Discovery Brochure More information from http://www.researchandmarkets.com/reports/314528/ Synthetic Biology, A New Paradigm For Biological Discovery Description: Synthetic biology's impact on the healthcare industry

More information

to enhance your cell culture using a Thermo Scientific CO 2 incubator with variable oxygen control

to enhance your cell culture using a Thermo Scientific CO 2 incubator with variable oxygen control Thermo Scientific CO 2 Incubators with Variable Oxygen Control 5 reasons to enhance your cell culture using a Thermo Scientific CO 2 incubator with variable oxygen control We use the Heracell tri-gas incubator

More information

STATISTICS AND CLINICAL PRACTICE

STATISTICS AND CLINICAL PRACTICE 139 th ICB SEMINAR Ninth International Seminar on STATISTICS AND CLINICAL PRACTICE Chairmen: Prof. Leon Bobrowski Prof. Ulrich Mansmann Dr. Cornelia Enăchescu WARSAW, June 1 4, 2014 PROGRAMME OF THE SEMINAR

More information

San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium Tuesday, December 9, EDUCATION SESSIONS 2:00 p.m. 5:30 p.m. Management of metastatic HER2 positive disease: optimizing current therapies and an overview of new agents in development - Ballroom B Reconstruction

More information

ROOM B 16.00-18.00 OPENING CEREMONY

ROOM B 16.00-18.00 OPENING CEREMONY 17 th September 2015 16.00-18.00 OPENING CEREMONY Introduction President of the Polish Pharmacological Society professor Marek Droździk Lecture in progress 50 years of the Polish Pharmacological Society

More information

Library in the educational area. Librarian 2.0 modernity based on the tradition

Library in the educational area. Librarian 2.0 modernity based on the tradition 23th May (Thursday) Library in the educational area. Librarian 2.0 modernity based on the tradition 8.00 9.00 Registration of participants. 23-24 May 2013 Conference program 9.00 9.30 Opening of the conference,

More information

Chapter 8. Summary and Perspectives

Chapter 8. Summary and Perspectives Chapter 8 Summary and Perspectives 131 Chapter 8 Summary Overexpression of the multidrug resistance protein MRP1 confer multidrug resistance (MDR) to cancer cells. The contents of this thesis describe

More information

Special Guest of the Congress. Changes in economic environment as an opportunity to improve competitiveness of listed companies

Special Guest of the Congress. Changes in economic environment as an opportunity to improve competitiveness of listed companies ORGANIZER 8 8 Changes in economic environment as an opportunity to improve competitiveness of listed companies Special Guest of the Congress Włodzimierz Karpiński, Minister of Treasury 17 th -18 th of

More information

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific

More information

ORGANISER: INSTITUTE FOR RENEWABLE ENERGY 13 TH -14 TH MAJA 2013R. ARTUS COURT, TORUŃ, POLAND

ORGANISER: INSTITUTE FOR RENEWABLE ENERGY 13 TH -14 TH MAJA 2013R. ARTUS COURT, TORUŃ, POLAND 6 TH INDUSTRY FORUM SOLAR ENERGY SOLAR COLLECTORS AND PHOTOVOLTAIC SYSTEMS IN PROSUMER ENERGY SYSTEMS Honorary Patronage: General Partner: Partners: Companion: Forum: ORGANISER: INSTITUTE FOR RENEWABLE

More information

The Biological Basis of Cancer. Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire

The Biological Basis of Cancer. Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire The Biological Basis of Cancer Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire Aim of Presentation By the end of this presentation you will: Be

More information

DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY

DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY Seminar The purpose of this course is to train students the skills of oral presentation about how to deliver seminar in an efficient way. For each talk, a professor

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version

More information

Clinical Cancer Research: Alternative IRB Models and Enhancing Progress

Clinical Cancer Research: Alternative IRB Models and Enhancing Progress Clinical Cancer Research: Alternative IRB Models and Enhancing Progress Lowell E. Schnipper, M.D. Berenson Professor of Medicine Chief, Hematology-Oncology Beth Israel Deaconess Medical Dynamics of Clinical

More information

Chapter 20: Biotechnology

Chapter 20: Biotechnology Name Period The AP Biology exam has reached into this chapter for essay questions on a regular basis over the past 15 years. Student responses show that biotechnology is a difficult topic. This chapter

More information

High Grade Gliomas: Update in Treatment and Care Ryan T. Merrell, M.D. Clinical Assistant Professor of Neurology NorthShore University HealthSystem

High Grade Gliomas: Update in Treatment and Care Ryan T. Merrell, M.D. Clinical Assistant Professor of Neurology NorthShore University HealthSystem High Grade Gliomas: Update in Treatment and Care Ryan T. Merrell, M.D. Clinical Assistant Professor of Neurology NorthShore University HealthSystem rmerrell@northshore.org Objectives Provide updates on

More information

Biology 271: Heredity, Fall 2016

Biology 271: Heredity, Fall 2016 Biology 271: Heredity, Fall 2016 Biology 271, 3.0 credits Tuesday and Thursday 1:00 PM 2:15 PM Room: ISC 131 Prerequisites: college level biology course or permission Note: This class cannot be used for

More information

Griffith University - Case for Support. Mesothelioma Research Program

Griffith University - Case for Support. Mesothelioma Research Program Griffith University - Case for Support Mesothelioma Research Program Professor Lyn Griffiths Director, Dean, Research and Director, Genomics Research Centre (GHI) Established in 2007. Integrated health

More information

International Symposium on Malignant Mesothelioma 2011 -- curemeso.org

International Symposium on Malignant Mesothelioma 2011 -- curemeso.org Measles virotherapy for malignant mesothelioma Manish R. Patel, D.O. Assistant Professor of Medicine University of Minnesota June 25, 2011 Medical Treatment of Mesothelioma Majority of patients are not

More information

PROGRAM FOR THE CONFERENCE. Frontiers in Cancer Research and Therapy. Karolinska Institutet, Nobel Forum, March 5-6, 2015

PROGRAM FOR THE CONFERENCE. Frontiers in Cancer Research and Therapy. Karolinska Institutet, Nobel Forum, March 5-6, 2015 Photo: Science Photo Library PROGRAM FOR THE CONFERENCE F 2015 Frontiers in Cancer Research and Therapy Karolinska Institutet, Nobel Forum, March 5-6, 2015 5 MARCH 2015, THURSDAY, NOBEL FORUM KAROLINSKA

More information

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational

More information

What s New in Ovarian Cancer Research? Novel Therapeutics for Ovarian Cancer

What s New in Ovarian Cancer Research? Novel Therapeutics for Ovarian Cancer What s New in Ovarian Cancer Research? Novel Therapeutics for Ovarian Cancer Scott Kaufmann, M.D., Ph.D. Mayo Clinic Division of Oncology Research October 27, 2012 Where we are now. Surgery Front-line

More information

Senyo Agbenowu M.S Student Email: senyagbe@pharmacy.isu.edu Advisor: Dr. Daniels My research interest is studying the role of histone deacetylases

Senyo Agbenowu M.S Student Email: senyagbe@pharmacy.isu.edu Advisor: Dr. Daniels My research interest is studying the role of histone deacetylases Senyo Agbenowu M.S Student Email: senyagbe@pharmacy.isu.edu Advisor: Dr. Daniels My research interest is studying the role of histone deacetylases (HDAC) in Dexamethasone resistance in Interleukin 6 (IL6)

More information

Cancer Gene Therapy: Challenges and Opportunities

Cancer Gene Therapy: Challenges and Opportunities ANTICANCER RESEARCH 24: xxx-xxx (2004) No: 4643-S Please mark the appropriate section for this paper Experimental Clinical Epidemiological Review Cancer Gene Therapy: Challenges and Opportunities KEVIN

More information

Myeloid Leukemias - Current and Future Approaches to Targeted and Individualized Therapies

Myeloid Leukemias - Current and Future Approaches to Targeted and Individualized Therapies Myeloid Leukemias - Current and Future Approaches to Targeted and Individualized Therapies Robert J. Arceci, M.D., Ph.D. King Fahd Professor of Pediatric Oncology Professor of Pediatrics, Oncology and

More information

Benefits in oncology. Mechanism of action

Benefits in oncology. Mechanism of action Mechanism of action The word cancer refers to a number of different diseases that share a common trait: the rapid, unrestrained growth and spread of cells that can invade and destroy surrounding tissues,

More information

Hospice care for children in Poland - achievements, challenges and perspectives

Hospice care for children in Poland - achievements, challenges and perspectives An announcement no 1 of the International Scientific Conference on the 10th anniversary of the Malopolska Hospice for Children Dear Sir/Madam, Hospice care for children is a socially important issue that

More information

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics EPAAC WP8 Research Forum - 2 July, Sofitel Hotel Europe, Brussels Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics JY Blay, Past President EORTC

More information

Cancer: DNA Synthesis, Mitosis, and Meiosis

Cancer: DNA Synthesis, Mitosis, and Meiosis Chapter 5 Cancer: DNA Synthesis, Mitosis, and Meiosis Copyright 2007 Pearson Copyright Prentice Hall, 2007 Inc. Pearson Prentice Hall, Inc. 1 What Is Cancer? Benign tumors do not invade surrounding tissue

More information